Page 26 - Alkermes News Today

The preliminary efficacy, safety, and optimal dose of the MUC16xCD3 bispecific antibody ubamatamab alone or in combination with cemiplimab-rwlc continues to be explored in patients with advanced platinum-resistant ovarian cancer in the phase 2 portion of an ongoing, first-in-human, phase 1/2 study.

HC Wainwright restated their neutral rating on shares of Alkermes (NASDAQ:ALKS – Free Report) in a research note released on Thursday, Benzinga reports. They currently have a $34.00 price target on the stock. Other analysts also recently issued reports about the company. JPMorgan Chase & Co. lifted their price target on Alkermes from $29.00 to […]

Emerald Mutual Fund Advisers Trust grew its stake in Alkermes plc (NASDAQ:ALKS – Free Report) by 48.6% during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 568,314 shares of the company’s stock after purchasing an additional 185,807 shares during the quarter. Emerald […]

Psychiatry's medicalization of social and psychological suffering is not justified by the currently known biology.

DUBLIN — DUBLIN — Alkermes PLC on Wednesday reported second-quarter net income of $237.1 million, after reporting a loss in the same period a year earlier. On a per-share basis, the...

Second Quarter 2023 Financial Results & Business Update July 26, 2023 ©...

Alkermes plc (NASDAQ: ALKS) reported Q2 adjusted EPS of $0.55 compared to $0.06 a year ago, missing the consensus of $0.56

Alkermes plc (NASDAQ:ALKS – Free Report) – SVB Leerink increased their FY2023 EPS estimates for Alkermes in a research note issued to investors on Sunday, July 23rd. SVB Leerink analyst M. Goodman now expects that the company will post earnings of $1.09 per share for the year, up from their previous forecast of $0.93. The […]

Before U.S. markets open Wednesday morning, 56 companies are scheduled to report quarterly earnings results. The following table is based on data from Briefing.com and includes a consensus forecast in dollars for quarterly earnings per share and EPS reported last year, and the consensus forecast for quarterly revenue in thousands of dollars. Companies marked with […]

Why Moms Are Ditching Happy Hour and Exploring Going ‘Sober Curious’ One fad of modern motherhood is the social acceptability of alcohol use, which is represent